Doctor’s Doubts Imperil a Lucrative Diabetes Drug
Findings by Dr. Peter C. Butler on Merck’s medication Januvia are threatening the future of all drugs in its class, which has annual sales of more than $9 billion. [Source]
Publication Date:Origin: nytimes.com
Category: Pancreatic Cancer
Topics: , billion, sales, annual, which, class, drugs, future, threatening, Januvia, medication, Merck’s, Butler, Peter, Findings, Diabetes, Lucrative, Imperil, Doubts, Doctor’s